|
Vaccine Detail
Herpes simplex virus DNA vaccine gBDNA encoding gB |
Vaccine Information |
- Vaccine Name: Herpes simplex virus DNA vaccine gBDNA encoding gB
- Target Pathogen: Herpes simplex virus type 1 and 2
- Target Disease: Herpes
- Vaccine Ontology ID: VO_0004369
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- UL27 from Herpes simplex virus type 1
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine expressed glycoprotein B of HSV (gBDNA) (Toka and Rouse, 2005).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005031
- Immunization Route: intranasal immunization
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: pIL-15 generated memory CD8 T cell responses that were threefold higher and mainly maintained in the spleen, but high levels of immunoglobulin A antibodies were induced and maintained long-term in the vaginal mucosa (Toka and Rouse, 2005).
- Efficacy: The enhanced immune responses ensuing from this strategy of immunization were protective upon lethal challenge with HSV-1. Five out of six mice survived after challenge (Toka and Rouse, 2005).
|
References |
Toka and Rouse, 2005: Toka FN, Rouse BT. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. Journal of leukocyte biology. 2005; 78(1); 178-186. [PubMed: 15817700].
|
|